{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T13:34:26Z","timestamp":1786628066817,"version":"build-2736575974"},"reference-count":145,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.bbrc.2026.154205","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T06:31:30Z","timestamp":1782455490000},"page":"154205","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Research progress on the association between diabetes mellitus and risk of cancer: From epidemiology to molecular mechanisms"],"prefix":"10.1016","volume":"829","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-4519-0711","authenticated-orcid":false,"given":"Yuxuan","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhan","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0208-0481","authenticated-orcid":false,"given":"Shanyi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2026.154205_bib1","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.2337\/dc23-S002","article-title":"2. Classification and diagnosis of diabetes: standards of care in Diabetes-2023","volume":"46","author":"ElSayed","year":"2023","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bbrc.2026.154205_bib2","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1007\/s11255-016-1316-x","article-title":"Diabetes and the risk of biochemical recurrence in patients with treated localized prostate cancer: a meta-analysis","volume":"48","author":"Hua","year":"2016","journal-title":"Int. Urol. Nephrol."},{"key":"10.1016\/j.bbrc.2026.154205_bib3","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1080\/07357907.2023.2171050","article-title":"Poorly controlled diabetes mellitus increases the risk of deaths and castration-resistance in locally advanced prostate cancer patients","volume":"41","author":"Ma","year":"2023","journal-title":"Cancer Invest."},{"key":"10.1016\/j.bbrc.2026.154205_bib4","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/ndt\/gfaf177","article-title":"IDF diabetes Atlas 11th edition 2025: global prevalence and projections for 2050","volume":"41","author":"Duncan","year":"2025","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.bbrc.2026.154205_bib5","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"Ca - Cancer J. Clin."},{"key":"10.1016\/j.bbrc.2026.154205_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25137476","article-title":"Associations between diabetes mellitus and selected cancers","volume":"25","author":"Pliszka","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2026.154205_bib7","article-title":"Organ-specific metabolic pathways distinguish prediabetes, type 2 diabetes, and normal tissues","volume":"3","author":"Diamanti","year":"2022","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.bbrc.2026.154205_bib8","doi-asserted-by":"crossref","first-page":"4939","DOI":"10.3748\/wjg.v27.i30.4939","article-title":"Diabetes and pancreatic cancer: exploring the two-way traffic","volume":"27","author":"Roy","year":"2021","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bbrc.2026.154205_bib9","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.50408","article-title":"Glucagon-like Peptide-1 receptor agonists and pancreatic cancer risk in patients with type 2 diabetes","volume":"7","author":"Dankner","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.bbrc.2026.154205_bib10","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s10549-023-07043-6","article-title":"Breast cancer and incidence of type 2 diabetes mellitus: a systematic review and meta-analysis","volume":"202","author":"Jordt","year":"2023","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.bbrc.2026.154205_bib11","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s44197-024-00237-1","article-title":"Global burden and trends of primary liver cancer attributable to comorbid type 2 diabetes mellitus among people living with hepatitis B: an observational trend study from 1990 to 2019","volume":"14","author":"Xie","year":"2024","journal-title":"Journal of Epidemiology and Global Health"},{"key":"10.1016\/j.bbrc.2026.154205_bib12","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1001\/jamaoncol.2025.2681","article-title":"GLP-1 receptor agonists and cancer risk in adults with obesity","volume":"11","author":"Dai","year":"2025","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.bbrc.2026.154205_bib13","author":"Nicholas Yell"},{"key":"10.1016\/j.bbrc.2026.154205_bib14","doi-asserted-by":"crossref","first-page":"799","DOI":"10.4093\/dmj.2021.0077","article-title":"Obesity, diabetes, and increased cancer progression","volume":"45","author":"Kim","year":"2021","journal-title":"Diabetes Metab. J"},{"key":"10.1016\/j.bbrc.2026.154205_bib15","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1210\/clinem\/dgad450","article-title":"New Horizons: Epidemiology of obesity, diabetes mellitus, and cancer prognosis","volume":"109","author":"Harborg","year":"2024","journal-title":"J. Clin. Endocrinol. Metabol."},{"key":"10.1016\/j.bbrc.2026.154205_bib16","doi-asserted-by":"crossref","DOI":"10.1210\/endrev\/bnz014","article-title":"Review: diabetes, obesity, and cancer-pathophysiology and clinical implications","volume":"41","author":"Lega","year":"2020","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.bbrc.2026.154205_bib27","doi-asserted-by":"crossref","first-page":"386","DOI":"10.15403\/jgld-5527","article-title":"Long-term risk of colorectal cancer in patients with prediabetes: a comprehensive systematic review and meta-analysis","volume":"33","author":"Keesari","year":"2024","journal-title":"J. Gastrointest. Liver Dis."},{"key":"10.1016\/j.bbrc.2026.154205_bib22","doi-asserted-by":"crossref","first-page":"9584","DOI":"10.18632\/aging.205886","article-title":"The association between diabetes mellitus and prostate cancer: a meta-analysis and Mendelian randomization","volume":"16","author":"Ye","year":"2024","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.bbrc.2026.154205_bib21","article-title":"Association between gestational diabetes mellitus and risk of breast cancer: a systematic review and meta-analysis","volume":"16","author":"Li","year":"2025","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.bbrc.2026.154205_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25094615","article-title":"Strengthening the evidence for a causal link between type 2 diabetes mellitus and pancreatic cancer: insights from two-sample and multivariable Mendelian randomization","volume":"25","author":"Ke","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2026.154205_bib25","article-title":"Complex interplay between type 2 diabetes mellitus and pancreatic cancer: insights from observational and mendelian randomization analyses","volume":"25","author":"Wang","year":"2025","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbrc.2026.154205_bib19","article-title":"Cancer and diabetes co-occurrence: a national study with 44 million person-years of follow-up","volume":"17","author":"Mordaunt","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2026.154205_bib17","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1093\/jnci\/djaa141","article-title":"Incident type 2 diabetes duration and cancer risk: a prospective study in two US cohorts","volume":"113","author":"Hu","year":"2021","journal-title":"JNCI: J. Natl. Cancer Inst."},{"key":"10.1016\/j.bbrc.2026.154205_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2025.109210","article-title":"Age at type 2 diabetes diagnosis and risk of cancer: cohort study in over 1 million individuals from the TriNetX US collaborative network","volume":"40","author":"Slater","year":"2026","journal-title":"J. Diabetes Complicat."},{"key":"10.1016\/j.bbrc.2026.154205_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2025.1638565","article-title":"Young patients with type 2 diabetes have high relative risks for complications in a country with middle-high sociodemographic index, similarly to those countries with high index","volume":"16","author":"Moln\u00e1r","year":"2025","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.bbrc.2026.154205_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1308561","article-title":"Inverse association between type 2 diabetes and hepatocellular carcinoma in East Asian populations","volume":"14","author":"Huo","year":"2024","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.bbrc.2026.154205_bib20","doi-asserted-by":"crossref","DOI":"10.1186\/s13058-024-01908-4","article-title":"Breast cancer in women with previous gestational diabetes: a nationwide register-based cohort study","volume":"26","author":"Christensen","year":"2024","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.bbrc.2026.154205_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2025.1725065","article-title":"Diabetes and tumor risk: a 23-year Danish national cohort study","volume":"16","author":"Skovbjerg","year":"2026","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.bbrc.2026.154205_bib26","first-page":"1043","article-title":"Type 2 diabetes mellitus and post-colonoscopy colorectal cancer: clinical and molecular characteristics and survival","volume":"35","author":"Boysen","year":"2024","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.bbrc.2026.154205_bib30","first-page":"2008","volume":"vol. 395","author":"Mizrahi","year":"2020"},{"key":"10.1016\/j.bbrc.2026.154205_bib31","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/S0140-6736(25)00261-2","article-title":"Pancreatic cancer","volume":"405","author":"Stoop","year":"2025","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.bbrc.2026.154205_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2025.1698850","article-title":"Risk factors and early prediction of pancreatic cancer among patients with diabetes mellitus: a systematic review and meta-analysis","volume":"16","author":"Cong","year":"2025","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.bbrc.2026.154205_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2025.101414","article-title":"The bidirectional link between diabetes and pancreatic cancer: a diagnostic aid, risk factor, and potential target for future therapy","volume":"106","author":"Verhoeff","year":"2025","journal-title":"Mol. Aspect. Med."},{"key":"10.1016\/j.bbrc.2026.154205_bib34","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.70388","article-title":"Predicting pancreatic cancer in new-onset diabetes cohort using a novel model with integrated clinical and genetic indicators: a large-scale prospective cohort study","volume":"13","author":"Sun","year":"2024","journal-title":"Cancer Med."},{"key":"10.1016\/j.bbrc.2026.154205_bib35","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1186\/s12885-023-11344-w","article-title":"Association between pancreatic cancer and diabetes: insights from a retrospective cohort study","volume":"23","author":"Amri","year":"2023","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbrc.2026.154205_bib36","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/s41416-022-01807-5","article-title":"Lifestyle, body mass index, diabetes, and the risk of pancreatic cancer in a nationwide population-based cohort study with 7.4 million Korean subjects","volume":"127","author":"Park","year":"2022","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbrc.2026.154205_bib37","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.1097\/MS9.0000000000002036","article-title":"Bidirectional relationship between pancreatic cancer and diabetes mellitus: a comprehensive literature review","volume":"86","author":"Sapoor","year":"2012","journal-title":"Annals of medicine and surgery"},{"key":"10.1016\/j.bbrc.2026.154205_bib38","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.pan.2021.02.001","article-title":"Validation of the ENDPAC model: identifying new-onset diabetics at risk of pancreatic cancer","volume":"21","author":"Khan","year":"2021","journal-title":"Pancreatology : official journal of the International Association of Pancreatology (IAP)"},{"key":"10.1016\/j.bbrc.2026.154205_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmpb.2023.107965","article-title":"Prediction of pancreatic cancer risk in patients with new-onset diabetes using a machine learning approach based on routine biochemical parameters","volume":"244","author":"Cichosz","year":"2024","journal-title":"Comput. Methods Progr. Biomed."},{"key":"10.1016\/j.bbrc.2026.154205_bib40","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1038\/s41416-024-02693-9","article-title":"Predicting the risk of pancreatic cancer in adults with new-onset diabetes: development and internal-external validation of a clinical risk prediction model","volume":"130","author":"Clift","year":"2024","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbrc.2026.154205_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2025.102139","article-title":"Comparisons of global incidence and risk factor profiles of hepatocellular carcinoma and intrahepatic cholangiocarcinoma","volume":"31","author":"Wu","year":"2026","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.bbrc.2026.154205_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.deman.2021.100025","article-title":"Impact of diabetes on the increased risk of hepatic cancer: an updated review of biological aspects","volume":"4","author":"Kumar Das","year":"2021","journal-title":"Diabetes Epidemiology and Management"},{"key":"10.1016\/j.bbrc.2026.154205_bib43","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/ijc.34965","article-title":"Diabetes is associated with increased liver cancer incidence and mortality in adults: a report from Asia cohort consortium","volume":"155","author":"Ho","year":"2024","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbrc.2026.154205_bib44","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1002\/ijc.26165","article-title":"Increased risk of hepatocellular carcinoma in patients with diabetes mellitus: a systematic review and meta-analysis of cohort studies","volume":"130","author":"Wang","year":"2012","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbrc.2026.154205_bib45","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S2468-1253(23)00157-7","article-title":"Type 2 diabetes, hepatic decompensation, and hepatocellular carcinoma in patients with non-alcoholic fatty liver disease: an individual participant-level data meta-analysis","volume":"8","author":"Huang","year":"2023","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbrc.2026.154205_bib46","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/CEJ.0000000000000669","article-title":"Associations between diabetes mellitus and the risk of hepatocellular carcinoma in Asian individuals with hepatitis B and C infection: systematic review and a meta-analysis of cohort studies","volume":"31","author":"Yang","year":"2022","journal-title":"Eur. J. Cancer Prev. : the official journal of the European Cancer Prevention Organisation (ECP)"},{"key":"10.1016\/j.bbrc.2026.154205_bib47","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1080\/07435800.2024.2361160","article-title":"Association between prediabetes and risk, mortality of hepatocellular carcinoma: a meta-analysis","volume":"49","author":"Ding","year":"2024","journal-title":"Endocr. Res."},{"key":"10.1016\/j.bbrc.2026.154205_bib48","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1002\/hep.32439","article-title":"Diabetes medications and risk of HCC","volume":"76","author":"Plaz Torres","year":"2022","journal-title":"Hepatology (Baltimore, Md"},{"key":"10.1016\/j.bbrc.2026.154205_bib49","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2025.1624896","article-title":"Navigating the nexus of type 2 diabetes mellitus and breast cancer: a comprehensive review of co-occurrence","volume":"15","author":"Saroosh","year":"2025","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbrc.2026.154205_bib50","article-title":"The hidden pathway: biological aging as a mediator between diabetes and breast cancer risk: a Mendelian randomized study","volume":"16","author":"Zhao","year":"2025","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.bbrc.2026.154205_bib51","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/s41416-023-02345-4","article-title":"Diabetes mellitus and risk of breast cancer: a large-scale, prospective, population-based study","volume":"129","author":"Xiong","year":"2023","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbrc.2026.154205_bib52","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-89288-3","article-title":"A two-sample Mendelian randomization study of type 1 diabetes and the risk of 22 site-specific cancers","volume":"15","author":"Getu","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2026.154205_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e16151","article-title":"Bioinformatics and network biology approach to identifying type 2 diabetes genes and pathways that influence the progression of breast cancer","volume":"9","author":"Sarkar","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.bbrc.2026.154205_bib54","article-title":"The relationship between gestational diabetes and the risk of cancer: a systematic review","volume":"16","author":"Slouha","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.bbrc.2026.154205_bib55","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1038\/bjc.2017.34","article-title":"Gestational diabetes mellitus may be associated with increased risk of breast cancer","volume":"116","author":"Park","year":"2017","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbrc.2026.154205_bib56","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s10552-021-01526-x","article-title":"Type 2 diabetes and all-cause mortality among Spanish women with breast cancer","volume":"33","author":"Fern\u00e1ndez-Arce","year":"2022","journal-title":"Cancer causes & control : CCC (Cancer Causes Control)"},{"key":"10.1016\/j.bbrc.2026.154205_bib57","doi-asserted-by":"crossref","first-page":"285","DOI":"10.4093\/dmj.2020.0250","article-title":"Hyperinsulinemia in obesity, inflammation, and cancer","volume":"45","author":"Zhang","year":"2021","journal-title":"Diabetes & metabolism journal"},{"key":"10.1016\/j.bbrc.2026.154205_bib58","doi-asserted-by":"crossref","first-page":"6026","DOI":"10.3748\/wjg.v21.i19.6026","article-title":"Association of type 2 diabetes mellitus and the risk of colorectal cancer: a meta-analysis and systematic review","volume":"21","author":"Guraya","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bbrc.2026.154205_bib59","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003431","article-title":"Risk of colorectal cancer in patients with diabetes mellitus: a Swedish nationwide cohort study","volume":"17","author":"Ali Khan","year":"2020","journal-title":"PLoS Med."},{"key":"10.1016\/j.bbrc.2026.154205_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2025.112187","article-title":"Family history of diabetes mellitus and risk of colorectal cancer: a nationwide cohort study","volume":"224","author":"Chen","year":"2025","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.bbrc.2026.154205_bib61","first-page":"1218","article-title":"Type 2 diabetes and cancer: an umbrella review of observational and mendelian randomization studies, cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the","volume":"30","author":"Pearson-Stuttard","year":"2021","journal-title":"American Society of Preventive Oncology"},{"key":"10.1016\/j.bbrc.2026.154205_bib62","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.43333","article-title":"Type 2 diabetes and colorectal cancer risk","volume":"6","author":"Lawler","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.bbrc.2026.154205_bib63","first-page":"186","article-title":"Physical activity, genetic susceptibility, and risk of colorectal cancer in type 2 diabetes: a large population-based cohort study","volume":"122","author":"Wu","year":"2025","journal-title":"Deutsches Arzteblatt international"},{"key":"10.1016\/j.bbrc.2026.154205_bib64","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1186\/s12876-024-03477-4","article-title":"Effect of diabetes mellitus type 2 and sulfonylurea on colorectal cancer development: a case-control study","volume":"24","author":"Rezazadeh","year":"2024","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.bbrc.2026.154205_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.dsx.2023.102828","article-title":"Association of diabetes mellitus with early-onset colorectal cancer: a systematic review and meta-analysis of 19 studies including 10 million individuals and 30,000 events","volume":"17","author":"Khoa Ta","year":"2023","journal-title":"Diabetes Metabol. Syndr."},{"key":"10.1016\/j.bbrc.2026.154205_bib66","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1007\/s11695-022-06155-0","article-title":"Colorectal cancer risk is impacted by sex and type of surgery after bariatric surgery","volume":"32","author":"Hussan","year":"2022","journal-title":"Obes. Surg."},{"key":"10.1016\/j.bbrc.2026.154205_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.canep.2025.102879","article-title":"The association of type 2 diabetes and its complications with the risk of colorectal cancer","volume":"98","author":"M\u00e4kinen","year":"2025","journal-title":"Cancer epidemiology"},{"key":"10.1016\/j.bbrc.2026.154205_bib68","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1136\/gutjnl-2023-331701","article-title":"Optimal glycaemic control and the reduced risk of colorectal adenoma and cancer in patients with diabetes: a population-based cohort study","volume":"73","author":"Mao","year":"2024","journal-title":"Gut"},{"key":"10.1016\/j.bbrc.2026.154205_bib69","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/ijc.30480","article-title":"Prospective study of type 2 diabetes mellitus, anti-diabetic drugs and risk of prostate cancer","volume":"140","author":"H\u00e4ggstr\u00f6m","year":"2017","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbrc.2026.154205_bib70","doi-asserted-by":"crossref","first-page":"441","DOI":"10.7314\/APJCP.2013.14.1.441","article-title":"Diabetes mellitus reduces prostate cancer risk - no function of age at diagnosis or duration of disease","volume":"14","author":"Xu","year":"2013","journal-title":"Asian Pac. J. Cancer Prev. APJCP : Asian Pac. J. Cancer Prev. APJCP"},{"key":"10.1016\/j.bbrc.2026.154205_bib71","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s10552-013-0334-6","article-title":"Type 2 diabetes and the risk of mortality among patients with prostate cancer","volume":"25","author":"Bensimon","year":"2014","journal-title":"Cancer causes & control : CCC (Cancer Causes Control)"},{"key":"10.1016\/j.bbrc.2026.154205_bib72","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1186\/s12885-025-14809-2","article-title":"Assessing the relationship between cardiometabolic diseases and the risk of developing aggressive prostate cancer: a systematic review and meta-analysis","volume":"25","author":"Amirmokri","year":"2025","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbrc.2026.154205_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2025.101420","article-title":"Cross-talk between cancer and diabetes: exploring shared molecular pathways in cellular metabolism and signaling","volume":"106","author":"Tang","year":"2025","journal-title":"Mol. Aspect. Med."},{"key":"10.1016\/j.bbrc.2026.154205_bib74","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21176275","article-title":"Pathophysiology of type 2 diabetes mellitus","volume":"21","author":"Galicia-Garcia","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2026.154205_bib75","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1226655","article-title":"Insulin signaling and its application","volume":"14","author":"Le","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.bbrc.2026.154205_bib76","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1038\/s12276-023-01101-1","article-title":"A stepwise activation model for the insulin receptor","volume":"55","author":"Yunn","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.bbrc.2026.154205_bib77","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics14192132","article-title":"The interlinking metabolic association between type 2 diabetes mellitus and cancer: molecular mechanisms and therapeutic insights","volume":"14","author":"Asiri","year":"2024","journal-title":"Diagnostics"},{"key":"10.1016\/j.bbrc.2026.154205_bib78","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12575","article-title":"Insulin promotes invasion and migration of KRAS(G12D) mutant HPNE cells by upregulating MMP-2 gelatinolytic activity via ERK- and PI3K-dependent signalling","volume":"52","author":"Wang","year":"2019","journal-title":"Cell Prolif."},{"key":"10.1016\/j.bbrc.2026.154205_bib79","doi-asserted-by":"crossref","first-page":"481","DOI":"10.3389\/fendo.2019.00481","article-title":"Insulin enhances migration and invasion in prostate cancer cells by Up-Regulation of FOXC2","volume":"10","author":"Sarkar","year":"2019","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.bbrc.2026.154205_bib80","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.ccell.2018.05.010","article-title":"ROS promotes cancer cell survival through calcium signaling","volume":"33","author":"Reczek","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbrc.2026.154205_bib81","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/s41568-021-00435-0","article-title":"The role of ROS in tumour development and progression","volume":"22","author":"Cheung","year":"2022","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbrc.2026.154205_bib82","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/cbf.3681","article-title":"The pro-proliferative effect of insulin in human breast epithelial DMBA-transformed and non-transformed cell lines is PI3K-, mTOR- and GLUT1-dependent","volume":"40","author":"Silva","year":"2022","journal-title":"Cell Biochem. Funct."},{"key":"10.1016\/j.bbrc.2026.154205_bib83","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3389\/fnmol.2011.00051","article-title":"PI3K\/AKT\/mTOR pathway in angiogenesis","volume":"4","author":"Karar","year":"2011","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.bbrc.2026.154205_bib84","first-page":"105","article-title":"Predicting the efficacy of trastuzumab-based therapy in breast cancer: current standards and future strategies","volume":"1786","author":"Singer","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbrc.2026.154205_bib85","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.mce.2015.08.013","article-title":"Metabolic, anabolic, and mitogenic insulin responses: a tissue-specific perspective for insulin receptor activators","volume":"415","author":"Bedinger","year":"2015","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.bbrc.2026.154205_bib86","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s00125-009-1558-6","article-title":"Mitogenic action of insulin: friend, foe or 'frenemy'?","volume":"53","author":"Draznin","year":"2010","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbrc.2026.154205_bib87","doi-asserted-by":"crossref","first-page":"179","DOI":"10.59298\/NIJSES\/2025\/63.179186","article-title":"The impact of hyperinsulinemia and hyperglycemia on cancer risk and progression in Obese diabetics","volume":"6","author":"Namukasa","year":"2025","journal-title":"Newport International Journal of Scientific and Experimental Sciences"},{"key":"10.1016\/j.bbrc.2026.154205_bib88","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1113\/JP278810","article-title":"Revisiting the Warburg effect: historical dogma versus current understanding","volume":"599","author":"Vaupel","year":"2021","journal-title":"J. Physiol."},{"key":"10.1016\/j.bbrc.2026.154205_bib89","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0203614","article-title":"Human cellular mitochondrial remodelling is governed by miR-2909 RNomics","volume":"13","author":"Malik","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2026.154205_bib90","doi-asserted-by":"crossref","DOI":"10.1038\/oncsis.2015.50","article-title":"Hypoxia and metabolic adaptation of cancer cells","volume":"5","author":"Eales","year":"2016","journal-title":"Oncogenesis"},{"key":"10.1016\/j.bbrc.2026.154205_bib91","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/path.6052","article-title":"Glycolysis and de novo fatty acid synthesis cooperatively regulate pathological vascular smooth muscle cell phenotypic switching and neointimal hyperplasia","volume":"259","author":"Cao","year":"2023","journal-title":"J. Pathol."},{"key":"10.1016\/j.bbrc.2026.154205_bib92","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.2174\/138955709788922610","article-title":"HIF-1alpha modulates energy metabolism in cancer cells by inducing over-expression of specific glycolytic isoforms","volume":"9","author":"Mar\u00edn-Hern\u00e1ndez","year":"2009","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.bbrc.2026.154205_bib93","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pbiomolbio.2025.05.003","article-title":"Advances in the mechanisms of HIF-1\u03b1-enhanced tumor glycolysis and its relation to dedifferentiation","volume":"197","author":"Zeng","year":"2025","journal-title":"Prog. Biophys. Mol. Biol."},{"key":"10.1016\/j.bbrc.2026.154205_bib94","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1113\/JP280572","article-title":"Regulation of glycolysis by the hypoxia-inducible factor (HIF): implications for cellular physiology","volume":"599","author":"Kierans","year":"2021","journal-title":"J. Physiol."},{"key":"10.1016\/j.bbrc.2026.154205_bib95","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1016\/j.molcel.2023.06.010","article-title":"Glucose-induced CRL4(COP1)-p53 axis amplifies glycometabolism to drive tumorigenesis","volume":"83","author":"Su","year":"2023","journal-title":"Mol Cell"},{"key":"10.1016\/j.bbrc.2026.154205_bib96","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21103613","article-title":"Role and mechanisms of RAGE-ligand complexes and RAGE-inhibitors in cancer progression","volume":"21","author":"El-Far","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2026.154205_bib97","article-title":"Effects of T2DM on cancer progression: pivotal precipitating factors and underlying mechanisms","volume":"15","author":"Zhang","year":"2024","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.bbrc.2026.154205_bib98","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0110542","article-title":"Cell migration is regulated by AGE-RAGE interaction in human oral cancer cells in vitro","volume":"9","author":"Ko","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2026.154205_bib99","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175861","article-title":"A specific RAGE-binding peptide inhibits triple negative breast cancer growth through blocking of Erk1\/2\/NF-kappaB pathway","volume":"954","author":"Dai","year":"2023","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbrc.2026.154205_bib100","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2021-002697","article-title":"Advanced glycation end products correlate with breast cancer metastasis by activating RAGE\/TLR4 signaling","volume":"10","author":"Pan","year":"2022","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/j.bbrc.2026.154205_bib101","doi-asserted-by":"crossref","DOI":"10.3390\/cells11152402","article-title":"The AGEs\/RAGE transduction signaling prompts IL-8\/CXCR1\/2-Mediated interaction between cancer-associated fibroblasts (CAFs) and breast cancer cells","volume":"11","author":"Santolla","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.bbrc.2026.154205_bib102","doi-asserted-by":"crossref","DOI":"10.1038\/s42003-026-10022-4","article-title":"Aging promotes a RAGE-dependent increase in breast cancer metastasis","volume":"9","author":"Miller","year":"2026","journal-title":"Commun. Biol."},{"key":"10.1016\/j.bbrc.2026.154205_bib103","doi-asserted-by":"crossref","DOI":"10.3389\/or.2024.1507942","article-title":"RAGE and its ligands in breast cancer progression and metastasis","volume":"18","author":"Coser","year":"2025","journal-title":"Oncol. Rev."},{"key":"10.1016\/j.bbrc.2026.154205_bib104","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s13046-023-02747-5","article-title":"The Ephrin tyrosine kinase a3 (EphA3) is a novel mediator of RAGE-prompted motility of breast cancer cells","volume":"42","author":"Talia","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bbrc.2026.154205_bib105","article-title":"The impact of advanced glycation end products and their receptors on the development and prognosis of colorectal cancer","author":"Wang","year":"2026","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbrc.2026.154205_bib106","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115575","article-title":"The role of HMGB1 in digestive cancer","volume":"167","author":"Chen","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bbrc.2026.154205_bib107","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216709","article-title":"S100A6 drives lymphatic metastasis of liver cancer via activation of the RAGE\/NF-k\u03baB\/VEGF-D pathway","volume":"587","author":"Chen","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbrc.2026.154205_bib108","article-title":"Correlation of serum IGF-1, AGEs and their receptors with the risk of colorectal cancer in patients with type 2 diabetes mellitus","volume":"13","author":"Chen","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbrc.2026.154205_bib109","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.semcancer.2020.11.019","article-title":"Effect of non-enzymatic glycosylation in the epigenetics of cancer","volume":"83","author":"Rehman","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.bbrc.2026.154205_bib110","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2023.1062229","article-title":"Advanced glycation end products regulate the receptor of AGEs epigenetically","volume":"11","author":"Wu","year":"2023","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bbrc.2026.154205_bib111","article-title":"Cancer cells change their glucose metabolism to overcome increased ROS: one step from cancer cell to cancer stem cell?","volume":"112","author":"Ghanbari Movahed","year":"2019","journal-title":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie"},{"key":"10.1016\/j.bbrc.2026.154205_bib112","series-title":"Oxidative Stress: Human Diseases and Medicine","first-page":"213","article-title":"Reactive oxygen species, glucose metabolism, and lipid metabolism","author":"Yang","year":"2021"},{"key":"10.1016\/j.bbrc.2026.154205_bib113","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20133374","article-title":"Glut 1 in cancer cells and the inhibitory action of resveratrol as A potential therapeutic strategy","volume":"20","author":"Zambrano","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2026.154205_bib114","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.cardiores.2006.09.012","article-title":"Role of NADPH oxidase 4 in lipopolysaccharide-induced proinflammatory responses by human aortic endothelial cells","volume":"72","author":"Park","year":"2006","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bbrc.2026.154205_bib115","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/s41419-025-07849-w","article-title":"Diabetes is causally associated with increased breast cancer mortality by inducing FIBCD1 to activate MCM5-mediated cell cycle arrest via modulating H3K27ac","volume":"16","author":"Tan","year":"2025","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbrc.2026.154205_bib116","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbagen.2025.130875","article-title":"Hyperglycemia accelerated the metastasis of triple-negative breast cancer via promoting TNF\u03b1\/Gli-1 axis in endothelial cells","volume":"1870","author":"Mei","year":"2026","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"10.1016\/j.bbrc.2026.154205_bib117","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2025.112027","article-title":"High glucose-induced mitochondrial fission drives pancreatic cancer progression through the H3K18la\/TTK\/BUB1B signal pathway","volume":"135","author":"Ding","year":"2025","journal-title":"Cell. Signal."},{"key":"10.1016\/j.bbrc.2026.154205_bib118","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/s41419-025-07499-y","article-title":"High glucose levels promote glycolysis and cholesterol synthesis via ERR\u03b1 and suppress the autophagy-lysosomal pathway in endometrial cancer","volume":"16","author":"Mao","year":"2025","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbrc.2026.154205_bib119","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217936","article-title":"YY1-glycolytic axis promotes high glucose-induced cancer stemness in endometrial cancer: a multi-omics guided therapeutic strategy","volume":"632","author":"Yang","year":"2025","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbrc.2026.154205_bib120","doi-asserted-by":"crossref","first-page":"509","DOI":"10.33549\/physiolres.934631","article-title":"Pathophysiological characteristics linking type 2 diabetes mellitus and colorectal Neoplasia","author":"Grega","year":"2021","journal-title":"Physiol. Res."},{"key":"10.1016\/j.bbrc.2026.154205_bib121","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2020.166044","article-title":"Diabetic fibrosis","volume":"1867","author":"Tuleta","year":"2021","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.bbrc.2026.154205_bib122","first-page":"1","article-title":"Diabetes and colorectal cancer risk: clinical and therapeutic implications","volume":"2022","author":"Yu","year":"2022","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.bbrc.2026.154205_bib123","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13956","article-title":"Is adipose tissue inflammation the culprit of obesity\u2010associated comorbidities?","volume":"26","author":"Turner","year":"2025","journal-title":"Obes. Rev."},{"key":"10.1016\/j.bbrc.2026.154205_bib124","doi-asserted-by":"crossref","DOI":"10.1016\/j.imbio.2025.153113","article-title":"Complement at the crossroads of inflammation and metabolism: implications for diabetes and metabolic functions","volume":"230","author":"Dandavate","year":"2025","journal-title":"Immunobiology"},{"key":"10.1016\/j.bbrc.2026.154205_bib125","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1625391","article-title":"Macrophages: friend or foe in diabetes pathogenesis and therapy","volume":"16","author":"Grimes","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbrc.2026.154205_bib126","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1111\/febs.16909","article-title":"Exploring the landscape of synthetic IL\u20106\u2010type cytokines","volume":"291","author":"Scheller","year":"2023","journal-title":"FEBS J."},{"key":"10.1016\/j.bbrc.2026.154205_bib127","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-023-04187-3","article-title":"IL-17A-mediated mitochondrial dysfunction induces pyroptosis in colorectal cancer cells and promotes CD8 + T-cell tumour infiltration","volume":"21","author":"Feng","year":"2023","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bbrc.2026.154205_bib128","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2025.102002","article-title":"Interleukin-1\u03b2 and cancer immune response","volume":"80","author":"R\u00e9b\u00e9","year":"2025","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.bbrc.2026.154205_bib129","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-025-06665-2","article-title":"Targeting inflammasomes as an immunotherapeutic strategy for cancer","volume":"23","author":"Huang","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bbrc.2026.154205_bib130","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-025-03366-y","article-title":"Role of inflammasomes in cancer immunity: mechanisms and therapeutic potential","volume":"44","author":"Singh","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bbrc.2026.154205_bib131","doi-asserted-by":"crossref","first-page":"8654","DOI":"10.1038\/s41467-025-63801-8","article-title":"Diabetes reshapes pancreatic cancer-associated endothelial niche by accelerating senescence","volume":"16","author":"Ling","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2026.154205_bib132","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/s43018-022-00353-6","article-title":"Perivascular tenascin C triggers sequential activation of macrophages and endothelial cells to generate a pro-metastatic vascular niche in the lungs","volume":"3","author":"Hongu","year":"2022","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.bbrc.2026.154205_bib133","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/cr.2008.316","article-title":"Roles of TGFbeta in metastasis","volume":"19","author":"Padua","year":"2009","journal-title":"Cell Res."},{"key":"10.1016\/j.bbrc.2026.154205_bib134","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/j.cmet.2025.07.008","article-title":"Tumor-associated Schwann cell remodeling under metabolic stress via lactate sensing orchestrates pancreatic ductal adenocarcinoma development","volume":"37","author":"Liu","year":"2025","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbrc.2026.154205_bib135","doi-asserted-by":"crossref","first-page":"4600","DOI":"10.1038\/s41467-023-40314-w","article-title":"Schwann cells regulate tumor cells and cancer-associated fibroblasts in the pancreatic ductal adenocarcinoma microenvironment","volume":"14","author":"Xue","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2026.154205_bib136","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1038\/s42003-025-08663-y","article-title":"Plasma exosomes from individuals with type 2 diabetes drive breast cancer aggression in patient-derived organoids","volume":"8","author":"Ennis","year":"2025","journal-title":"Commun. Biol."},{"key":"10.1016\/j.bbrc.2026.154205_bib137","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/s12875-024-02496-0","article-title":"Strategic use of resources to enhance colorectal cancer screening for patients with diabetes (SURE: CRC4D) in federally qualified health centers: a protocol for hybrid type ii effectiveness-implementation trial","volume":"25","author":"O'Malley","year":"2024","journal-title":"BMC Prim. Care"},{"key":"10.1016\/j.bbrc.2026.154205_bib138","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/apt.18435","article-title":"Risk-adapted starting ages of colorectal cancer screening for people with diabetes or metabolic syndrome","volume":"61","author":"Seum","year":"2025","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.bbrc.2026.154205_bib139","doi-asserted-by":"crossref","DOI":"10.1002\/jgh3.13062","article-title":"Risk prediction of advanced colorectal neoplasia among diabetic patients: a derivation and validation study","volume":"8","author":"Wong","year":"2024","journal-title":"JGH Open"},{"key":"10.1016\/j.bbrc.2026.154205_bib140","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16071325","article-title":"Role of SGLT2 inhibitors, DPP-4 inhibitors, and metformin in pancreatic cancer prevention","volume":"16","author":"Laeeq","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbrc.2026.154205_bib141","article-title":"New-onset diabetes as an emerging risk group for early detection of pancreatic cancer: current evidence, clinical challenge, and future directions","volume":"4","author":"Tao","year":"2025","journal-title":"Front Gastroenterol (Lausanne)"},{"key":"10.1016\/j.bbrc.2026.154205_bib142","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1186\/s12935-021-02202-5","article-title":"Cancer and diabetes: the interlinking metabolic pathways and repurposing actions of antidiabetic drugs","volume":"21","author":"Olatunde","year":"2021","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.bbrc.2026.154205_bib143","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.3784","article-title":"Comparison between sodium\u2010glucose cotransporter 2 inhibitors and dipeptidyl peptidase 4 inhibitors on the risk of incident cancer in patients with diabetes mellitus: a real\u2010world evidence study","volume":"40","author":"Sung","year":"2024","journal-title":"Diabetes Metabol. Res. Rev."},{"key":"10.1016\/j.bbrc.2026.154205_bib144","doi-asserted-by":"crossref","DOI":"10.3390\/biom12111580","article-title":"Tirzepatide-friend or foe in diabetic cancer patients?","volume":"12","author":"Samuel","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.bbrc.2026.154205_bib145","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22041680","article-title":"Diabetes, antidiabetic medications and cancer risk in type 2 diabetes: focus on SGLT-2 inhibitors","volume":"22","author":"Dabrowski","year":"2021","journal-title":"Int. J. Mol. Sci."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26009691?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26009691?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T12:53:48Z","timestamp":1786625628000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X26009691"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":145,"alternative-id":["S0006291X26009691"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.154205","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Research progress on the association between diabetes mellitus and risk of cancer: From epidemiology to molecular mechanisms","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.154205","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"154205"}}